# Rostock International Parkinson's Disease Study (ROPAD)

> **NCT03866603** · — · COMPLETED · sponsor: **CENTOGENE GmbH Rostock** · enrollment: 20112 (actual)

## Conditions studied

- Parkinson´s Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03866603
- **Lead sponsor:** CENTOGENE GmbH Rostock
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-30
- **Primary completion:** 2024-10-10
- **Final completion:** 2024-10-10
- **Target enrollment:** 20112 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03866603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03866603, "Rostock International Parkinson's Disease Study (ROPAD)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03866603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*